ChemCatChem
10.1002/cctc.201902051
COMMUNICATION
6
equivalents of D
2
O yielded 80% deuterium-incorporation (Table
Voges, J. R. Heys, T. Moenius, Preparation of Compounds
Labeled with Tritium and Carbon‐14, Wiley, Chichester, UK,
2009; e) C. S. Elmore, Annu. Rep. Med. Chem. 2009, 44,
S-2 in the Supporting Information). In addition, we also performed
the HIE of repaglinide (7) with freshly prepared D
case, we observed a decreased deuterium-incorporation in the
ortho-position (50%), which was nevertheless a promising result
2
In this
515–534.
[
3]
J. Atzrodt, V. Derdau, W. J. Kerr, M. Reid, Angew. Chem.
Int. Ed. 2018, 57, 1758–1784.
towards the use of T
2
O. Under slightly modified reaction
[4]
P. H. Allen, M. J. Hickey, L. P. Kingston, D. J. Wilkinson, J.
Label. Compd. Rad. 2010, 53, 731–738.
D. Hesk, C. F. Lavey, P. McNamara, J. Label. Compd. Rad.
conditions, we performed the tritium labelling of repaglinide (7).
Thus, were able to introduce tritium in moderate specific activity
in a single step (Scheme 5).
[
[
5]
6]
2010, 53, 722–730.
a) J. J. Verendel, O. Pàmies, M. Diéguez, P. G. Andersson,
Chem. Rev. 2014, 114, 2130–2169; b) J. S. Valsborg, L.
Sørensen, C. Foged, J. Label. Compd. Rad. 2001, 44, 209–
214; c) G. J. Ellames, J. S. Gibson, J. M. Herbert, A. H.
McNeill, Tetrahedron 2001, 57, 9487–9497; d) D. Hesk, P.
R. Das, B. Evans, J. Label. Compd. Rad. 1995, 36, 497–
502; e) R. Crabtree, Acc. Chem. Res. 1979, 12, 331–337.
[
7]
a) M. Valero, R. Weck, S. Güssregen, J. Atzrodt, V. Derdau,
Angew. Chem. Int. Ed. 2018, 57, 8159–8163; b) W. J. Kerr,
R. J. Mudd, M. Reid, J. Atzrodt, V. Derdau, ACS Catal. 2018,
8, 10895–10900; c) W. J. Kerr, M. Reid, T. Tuttle, Angew.
Chem. Int. Ed. 2017, 56, 7808–7812; d) W. J. Kerr, D. M.
Lindsay, M. Reid, J. Atzrodt, V. Derdau, P. Rojahn, R. Weck,
Chem. Commun. 2016, 52, 6669–6672; e) W. J. Kerr, M.
Reid, T. Tuttle, ACS Catal. 2015, 5, 402–410; f) W. J. Kerr,
R. J. Mudd, L. C. Paterson, J. A. Brown, Chem. Eur. J. 2014,
20, 14604–14607; g) J. A. Brown, A. R. Cochrane, S. Irvine,
Scheme 5. Tritiation of repaglinide via ruthenium catalyzed C–H-activation.
W. J. Kerr, B. Mondal, J. A. Parkinson, L. C. Paterson, M.
Reid, T. Tuttle, S. Andersson, G. N. Nilsson, Adv. Synth.
Catal. 2014, 356, 3551–3562; h) G. N. Nilsson, W. J. Kerr,
J. Label. Compd. Rad. 2010, 53, 662–667.
For notable progress, see: a) C. Zarate, H. Yang, M. J.
Bezdek, D. Hesk, P. J. Chirik, J. Am. Chem. Soc. 2019, 141,
In conclusion, we have reported on a novel ruthenium(II)-
catalyzed strategy for the selective HIE of pharmaceutical drugs
via late-stage diversification. Hence, carboxylate assistance
enabled versatile C–H deuteration with excellent levels of isotope
incorporation and functional group tolerance. In addition, we have
demonstrated a step-economical access to selectively tritium
labeled drugs, an essential tool for the development of new
therapeutics and molecular understanding.
[8]
5034–5044; b) M. Valero, D. Becker, K. Jess, R. Weck, J.
Atzrodt, T. Bannenberg, V. Derdau, M. Tamm, Chem. Eur.
J. 2019, 25, 6517–6522; c) T. R. Puleo, A. J. Strong, J. S.
Bandar, J. Am. Chem. Soc. 2019, 141, 1467–1472; d) A. L.
Garreau, H. Zhou, M. C. Young, Org. Lett. 2019, 21, 7044-
7048; e) V. H. Mai, O. B. Gadzhiev, S. K. Ignatov, G. I.
Nikonov, Catal. Sci. Tech. 2019, 9, 3398-3407; f) H. Yang,
C. Zarate, W. N. Palmer, N. Rivera, D. Hesk, P. J. Chirik,
ACS Catal. 2018, 8, 10210–10218; g) H. Yang, P. G.
Dormer, N. R. Rivera, A. J. Hoover, Angew. Chem. Int. Ed.
Acknowledgements
2
018, 57, 1883–1887; h) N. G. Léonard, P. J. Chirik, ACS
Generous support by the DFG (Gottfried-Wilhelm-Leibniz award
to LA, and SPP1807) are gratefully acknowledged.
Catal. 2018, 8, 342–348; i) R. P. Yu, J. M. Darmon, S. P.
Semproni, Z. R. Turner, P. J. Chirik, Organometallics 2017,
36, 4341–4343; j) W. N. Palmer, P. J. Chirik, ACS Catal.
2
017, 7, 5674–5678; k) S. K. S. Tse, P. Xue, C. W. S. Lau,
Keywords: C–H activation • hydrogen isotope exchange •
ruthenium • pharmaceutical drugs • tritium
H. H. Y. Sung, I. D. Williams, G. Jia, Chem. Eur. J. 2011,
17, 13918–13925; l) W. Bai, K.-H. Lee, S. K. S. Tse, K. W.
Chan, Z. Lin, G. Jia, Organometallics 2015, 34, 3686-3698;
m) W. J. S. Lockley, D. Hesk, J. Label. Compd. Rad. 2010,
[
1]
a) A. Mullard, Nat. Rev. Drug Discov. 2017, 16, 305; b) G.
S. Timmins, Expert Opin. Ther. Patents 2014, 24, 1067–
53, 704–715; n) M. H. Emmert, J. B. Gary, J. M. Villalobos,
M. S. Sanford, Angew. Chem. Int. Ed. 2010, 49, 5884–
1075; c) T. G. Gant, J. Med. Chem. 2014, 57, 3595–3611;
5886; o) J. Atzrodt, V. Derdau, J. Label. Compd. Rad. 2010,
d) B. Buscher, S. Laakso, H. Mascher, K. Pusecker, M.
Doig, L. Dillen, W. Wagner-Redeker, T. Pfeifer, P. Delrat, P.
Timmerman, Bioanalysis 2014, 6, 673–682; e) J. A. Krauser,
J. Label. Compd. Rad. 2013, 56, 441–446; f) A. Katsnelson,
Nat. Med. 2013, 19, 656; g) N. Penner, L. Xu, C. Prakash,
Chem. Res. Toxicol. 2012, 25, 513–531; h) J. J. Maguire,
R. E. Kuc, A. P. Davenport, in Receptor Binding Techniques
5
3, 674–685; p) J. A. Brown, S. Irvine, A. R. Kennedy, W.
J. Kerr, S. Andersson, G. N. Nilsson, Chem. Commun. 2008,
1115–1117; q) M. H. G. Prechtl, M. Hölscher, Y. Ben-David,
N. Theyssen, R. Loschen, D. Milstein, W. Leitner, Angew.
Chem. Int. Ed. 2007, 46, 2269–2272; r) S. R. Klei, J. T.
Golden, T. D. Tilley, R. G. Bergman, J. Am. Chem. Soc.
2002, 124, 2092–2093, and references cited therein.
(Ed.: A. P. Davenport), Humana Press, Totowa, NJ, 2012,
[
9]
a) S. Santoro, F. Ferlin, L. Ackermann, L. Vaccaro, Chem.
Soc. Rev. 2019, 48, 2767–2782; b) J. Loup, U. Dhawa, F.
Pesciaioli, J. Wencel-Delord, L. Ackermann, Angew. Chem.
Int. Ed. 2019, 58, 12803–12818; c) P. Gandeepan, T. Müller,
D. Zell, G. Cera, S. Warratz, L. Ackermann, Chem. Rev.
pp. 31–77; i) E. C. Hulme, M. A. Trevethick, Br. J.
Pharmacol. 2010, 161, 1219–1237; j) J. Atzrodt, V. Derdau,
T. Fey, J. Zimmermann, Angew. Chem. Int. Ed. 2007, 46,
7
744–7765.
a) C. S. Elmore, R. A. Bragg, Bioorg. Med. Chem. Lett.
015, 25, 167–171; b) W. J. S. Lockley, A. McEwen, R.
[
2]
2019, 119, 2192–2452; d) P. Gandeepan, N. Kaplaneris, S.
2
Santoro, L. Vaccaro, L. Ackermann, ACS Sustain. Chem.
Eng. 2019, 7, 8023–8040; e) C. Sambiagio, D. Schönbauer,
R. Blieck, T. Dao-Huy, G. Pototschnig, P. Schaaf, T.
Wiesinger, M. F. Zia, J. Wencel-Delord, T. Besset, B. U. W.
Cooke, J. Label. Compd. Rad. 2012, 55, 235–257; c) E. M.
Isin, C. S. Elmore, G. N. Nilsson, R. A. Thompson, L.
Weidolf, Chem. Res. Toxicol. 2012, 25, 532–542; d) R.
This article is protected by copyright. All rights reserved.